keyword
https://read.qxmd.com/read/38587601/patient-perspectives-on-pharmacogenomic-pgx-testing-for-antidepressant-prescribing-in-primary-care-a-qualitative-description-study
#21
JOURNAL ARTICLE
Alexandra Cernat, Zainab Samaan, Julia Abelson, Amanada Ramdyal, Hadia Shaikh, Meredith Vanstone
Many patients with major depressive disorder (MDD) try multiple antidepressants before finding one that works well and is tolerable. Pharmacogenomic (PGx) testing was developed to facilitate more efficacious prescribing. This technology has not been robustly implemented clinically. Patient perspectives are critical to policy decisions, but the views of patients with MDD about the use of PGx testing to guide antidepressant prescribing have not been extensively examined, particularly in publicly funded healthcare systems...
April 8, 2024: Journal of Community Genetics
https://read.qxmd.com/read/38586573/islamic-viewpoints-on-opportunistic-sex-selection-of-ivf-embryos-upon-doing-preimplantation-genetic-testing-for-preventing-genetic-diseases
#22
JOURNAL ARTICLE
Sayyed Mohamed Muhsin, Shaima Zohair Arab, Alexis Heng Boon Chin
In recent years, preimplantation genetic testing (PGT) of IVF embryos have gained much traction in clinical assisted reproduction for preventing various genetic defects, including Down syndrome. However, such genetic tests inevitably reveal the sex of IVF embryos by identifying the sex (X and Y) chromosomes. In many countries with less stringent IVF regulations, information on the sex of embryos that are tested to be genetically normal is readily shared with patients. This would thus present Muslim patients with unintended opportunities for sex selection based on personal or social biases without any pressing need or valid medical reason...
April 2024: Asian Bioethics Review
https://read.qxmd.com/read/38586568/all-you-need-is-trust-public-perspectives-on-consenting-to-participate-in-genomic-research-in-the-sri-lankan-district-of-colombo
#23
JOURNAL ARTICLE
Krishani Jayasinghe, W A S Chamika, Kaushalya Jayaweera, Kalpani Abhayasinghe, Lasith Dissanayake, Athula Sumathipala, Jonathan Ives
Engagement with genomic medicine and research has increased globally during the past few decades, including rapid developments in Sri Lanka. Genomic research is carried out in Sri Lanka on a variety of scales and with different aims and perspectives. However, there are concerns about participants' understanding of genomic research, including the validity of informed consent. This article reports a qualitative study aiming to explore the understanding, knowledge, and attitudes of the Sri Lankan public towards genomic medicine and to inform the development of an effective and appropriate process for informed consent in that setting...
April 2024: Asian Bioethics Review
https://read.qxmd.com/read/38585913/establishing-primary-and-stable-cell-lines-from-frozen-wing-biopsies-for-cellular-physiological-and-genetic-studies-in-bats
#24
Fengyan Deng, Pedro Morales-Sosa, Andrea Bernal-Rivera, Yan Wang, Dai Tsuchiya, Jose Emmanuel Javier, Nicolas Rohner, Chongbei Zhao, Jasmin Camacho
Bats stand out among mammalian species for their exceptional traits, including the capacity to navigate through flight and echolocation, conserve energy through torpor/hibernation, harbor a multitude of viruses, exhibit resistance to disease, survive harsh environmental conditions, and demonstrate exceptional longevity compared to other mammals of similar size. In vivo studies of bats can be challenging for several reasons such as ability to locate and capture them in their natural environments, limited accessibility, low sample size, environmental variation, long lifespans, slow reproductive rates, zoonotic disease risks, species protection, and ethical concerns...
March 27, 2024: bioRxiv
https://read.qxmd.com/read/38585270/advancing-kidney-xenotransplantation-with-anesthesia-and-surgery-bridging-preclinical-and-clinical-frontiers-challenges-and-prospects
#25
REVIEW
Xiaojian Zhang, Hailian Wang, Qin Xie, Yang Zhang, Yixin Yang, Man Yuan, Yuqi Cui, Si-Yuan Song, Jianzhen Lv, Yi Wang
Xenotransplantation is emerging as a vital solution to the critical shortage of organs available for transplantation, significantly propelled by advancements in genetic engineering and the development of sophisticated immunosuppressive treatments. Specifically, the transplantation of kidneys from genetically engineered pigs into human patients has made significant progress, offering a potential clinical solution to the shortage of human kidney supply. Recent trials involving the transplantation of these modified porcine kidneys into deceased human bodies have underscored the practicality of this approach, advancing the field towards potential clinical applications...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38584552/crispr-and-gene-editing-a-game-changer-in-drug-development
#26
JOURNAL ARTICLE
Abhishek Verma, Tarun Sharma, Ankit Awasthi
CRISPR and gene editing technologies have emerged as transformative tools in medicine, offering unprecedented precision in targeting genetic disorders and revolutionizing drug development. This review explores the multifaceted impact of CRISPR across various medical domains, from hereditary diseases to infectious diseases and cancer. The potential of CRISPR in personalized medicine, therapeutic innovation, and pandemic prevention is highlighted, along with its role in reshaping traditional drug development processes...
April 4, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38584046/achieving-comprehensive-patient-centered-cancer-services-optimizing-the-role-of-advanced-practice-nurses-at-the-core-of-precision-health
#27
JOURNAL ARTICLE
Sara Colomer-Lahiguera, Jenny Gentizon, Melissa Christofis, Célia Darnac, Andrea Serena, Manuela Eicher
OBJECTIVES: The field of oncology has been revolutionized by precision medicine, driven by advancements in molecular and genomic profiling. High-throughput genomic sequencing and non-invasive diagnostic methods have deepened our understanding of cancer biology, leading to personalized treatment approaches. Precision health expands on precision medicine, emphasizing holistic healthcare, integrating molecular profiling and genomics, physiology, behavioral, and social and environmental factors...
April 6, 2024: Seminars in Oncology Nursing
https://read.qxmd.com/read/38575304/phenotypic-characterisation-of-smad4-variant-carriers
#28
JOURNAL ARTICLE
Claire Caillot, Jean-Christophe Saurin, Valérie Hervieu, Marie Faoucher, Julie Reversat, Evelyne Decullier, Gilles Poncet, Sabine Bailly, Sophie Giraud, Sophie Dupuis-Girod
BACKGROUND: Both hereditary haemorrhagic telangiectasia (HHT) and juvenile polyposis syndrome (JPS) are known to be caused by SMAD4 pathogenic variants, with overlapping symptoms for both disorders in some patients. Additional connective tissue disorders have also been reported. Here, we describe carriers of SMAD4 variants followed in an HHT reference centre to further delineate the phenotype. METHODS: Observational study based on data collected from the Clinical Investigation for the Rendu-Osler Cohort database...
April 4, 2024: Journal of Medical Genetics
https://read.qxmd.com/read/38575303/-brca-awareness-and-testing-experience-in-the-uk-jewish-population-a-qualitative-study
#29
JOURNAL ARTICLE
Katrina Sarig, Samuel Oxley, Ashwin Kalra, Monika Sobocan, Caitlin T Fierheller, Michail Sideris, Tamar Gootzen, Michelle Ferris, Rosalind A Eeles, D Gareth Evans, Samantha L Quaife, Ranjit Manchanda
BACKGROUND: 1 in 40 UK Jewish individuals carry a pathogenic variant in BRCA1/BRCA2 . Traditional testing criteria miss half of carriers, and so population genetic testing is being piloted for Jewish people in England. There has been no qualitative research into the factors influencing BRCA awareness and testing experience in this group. This study aimed to explore these and inform improvements for the implementation of population genetic testing. METHODS: Qualitative study of UK Jewish adults who have undergone BRCA testing...
April 4, 2024: Journal of Medical Genetics
https://read.qxmd.com/read/38573068/genetics-and-genomics-of-pulmonary-fibrosis-charting-the-molecular-landscape-and-shaping-precision-medicine
#30
JOURNAL ARTICLE
Ayodeji Adegunsoye, Jonathan A Kropski, Juergen Behr, Timothy S Blackwell, Tamera J Corte, Vincent Cottin, Allan Glanville, Marilyn K Glassberg, Matthias Griese, Gary M Hunninghake, Kerri A Johannson, Michael P Keane, John S Kim, Martin Kolb, Toby M Maher, Justin M Oldham, Anna J Podolanczuk, Ivan O Rosas, Fernando J Martinez, Imre Noth, David A Schwartz
Recent genetic and genomic advancements have elucidated the complex etiology of idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic interstitial lung diseases (ILDs), emphasizing the contribution of heritable factors. This state-of-the-art review synthesizes evidence on significant genetic contributors to pulmonary fibrosis (PF), including rare genetic variants and common single nucleotide polymorphisms (SNPs). The MUC5B promoter variant is unusual, a common SNP that markedly elevates the risk of early and established PF...
April 4, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38569677/prospective-cohort-study-of-genomic-newborn-screening-babyscreen-pilot-study-protocol
#31
JOURNAL ARTICLE
Sebastian Lunke, Sophie E Bouffler, Lilian Downie, Jade Caruana, David J Amor, Alison Archibald, Yvonne Bombard, John Christodoulou, Marc Clausen, Paul De Fazio, Ronda F Greaves, Sebastian Hollizeck, Anaita Kanga-Parabia, Nitzan Lang, Fiona Lynch, Riccarda Peters, Simon Sadedin, Erin Tutty, Stefanie Eggers, Crystle Lee, Meaghan Wall, Alison Yeung, Clara Gaff, Christopher Gyngell, Danya F Vears, Stephanie Best, Ilias Goranitis, Zornitza Stark
INTRODUCTION: Newborn bloodspot screening (NBS) is a highly successful public health programme that uses biochemical and other assays to screen for severe but treatable childhood-onset conditions. Introducing genomic sequencing into NBS programmes increases the range of detectable conditions but raises practical and ethical issues. Evidence from prospectively ascertained cohorts is required to guide policy and future implementation. This study aims to develop, implement and evaluate a genomic NBS (gNBS) pilot programme...
April 3, 2024: BMJ Open
https://read.qxmd.com/read/38567981/advances-and-challenges-of-sensing-in-water-using-crispr-cas-technology
#32
REVIEW
Moein Safarkhani, Bahareh Farasati Far, Su-Hyeon Kim, Pooyan Makvandi, Mi-Kyung Park, YunSuk Huh, Navid Rabiee
The groundbreaking gene-editing mechanism, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), paired with the protein Cas9, has significantly advanced the realms of biology, medicine, and agriculture. Through its precision in modifying genetic sequences, CRISPR holds the potential to alter the trajectory of genetic disorders and accelerate advancements in agriculture. While its therapeutic potential is profound, the technology also invites ethical debates centered on responsible use and equity in access...
April 3, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38567606/the-crispr-cas9-induced-ccr5-%C3%AE-32-mutation-as-a-potent-gene-therapy-methodology-for-resistance-to-hiv-1-variant-a-review
#33
REVIEW
M Saifullah, O Laghzaoui, H Ozyahyalar, A Irfan
Human Immunodeficiency Virus (HIV) has continuously been the greatest epidemic for humanity over a period spanning almost five decades. With no specific cure or treatment available to date despite extensive research, the C-C Chemokine Receptor 5, Delta 32 (CCR5 Δ32) allele genetic point mutation plays an imperative role in the prevention of acquired immunodeficiency syndrome (AIDS). This comprehensive study aims to review the induction of the homozygous recessive deletion genotype using the Clustered Regularly Interspaced Short Palindromic Repeats, Cas 9 Enzyme (CRISPR-Cas9), and hematopoietic stem cell transplantation under positive selection pressure for active immunity in seropositive patients' populations as the phenotype...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38566857/recent-insights-from-non-mammalian-models-of-brain-injuries-an-emerging-literature
#34
REVIEW
Nicole J Katchur, Daniel A Notterman
Traumatic brain injury (TBI) is a major global health concern and is increasingly recognized as a risk factor for neurodegenerative diseases including Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE). Repetitive TBIs (rTBIs), commonly observed in contact sports, military service, and intimate partner violence (IPV), pose a significant risk for long-term sequelae. To study the long-term consequences of TBI and rTBI, researchers have typically used mammalian models to recapitulate brain injury and neurodegenerative phenotypes...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38564873/genetic-causes-of-infection-induced-encephalitis
#35
JOURNAL ARTICLE
Olivia-Paris Quinn, Peter McNaughton, Nolette Pereira, Kate Riney
INTRODUCTION: Patients with encephalitis following a viral infection are often thought to have a para infectious, inflammatory, or autoimmune cause for their presentation. These diagnoses usually result in treatments with immunosuppressant therapies which can have side effects. However, there is an increasing body of evidence demonstrating that patients can have a direct genetic cause mediating viral infection triggered encephalitis, where inflammation is a secondary response. These patients may benefit not from immunosuppressive therapies, but from protection from infection through dedicated immunisation programs and early antiviral therapies at times of infection...
March 20, 2024: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/38560484/crispr-cas9-gene-editing-curing-genetic-diseases-by-inherited-epigenetic-modifications
#36
REVIEW
Nikhil Deep Kolanu
Introduction  CRISPR-Cas9 gene editing, leveraging bacterial defense mechanisms, offers precise DNA modifications, holding promise in curing genetic diseases. This review critically assesses its potential, analyzing evidence on therapeutic applications, challenges, and future prospects. Examining diverse genetic disorders, it evaluates efficacy, safety, and limitations, emphasizing the need for a thorough understanding among medical professionals and researchers. Acknowledging its transformative impact, a systematic review is crucial for informed decision-making, responsible utilization, and guiding future research to unlock CRISPR-Cas9's full potential in realizing the cure for genetic diseases...
January 2024: Global medical genetics
https://read.qxmd.com/read/38555866/animal-models-of-neuropsychiatric-systemic-lupus-erythematosus-deciphering-the-complexity-and-guiding-therapeutic-development
#37
REVIEW
Baruh Polis, Carla M Cuda, Chaim Putterman
Systemic lupus erythematosus (SLE) poses formidable challenges due to its multifaceted etiology while impacting multiple tissues and organs and displaying diverse clinical manifestations. Genetic and environmental factors contribute to SLE complexity, with relatively limited approved therapeutic options. Murine models offer insights into SLE pathogenesis but do not always replicate the nuances of human disease. This review critically evaluates spontaneous and induced animal models, emphasizing their validity and relevance to neuropsychiatric SLE (NPSLE)...
December 2024: Autoimmunity
https://read.qxmd.com/read/38554341/biodosimetric-analysis-of-head-and-neck-cancer-patients-undergoing-radiotherapy-by-dicentric-chromosome-aberration-assay
#38
JOURNAL ARTICLE
Nayan Agarwal, Arun K Rathi, Seema Kapoor, Kishore Singh, Savita Arora, Ankur Jindal, Kumar Prabhat, Himanshi Kaushik
BACKGROUND: Biodosimetry is the quantification of absorbed radiation dose using biological material obtained from an exposed individual. Radiation can cause different types of chromosomal aberrations, including stable aberrations like translocations and unstable ones like micronuclei, dicentric chromosomes (DC), acentric, and ring forms. Dicentric chromosome assay has become the "gold standard" for cytogenetic biodosimetry due to its reproducibility, specificity (low baseline rates), and sensitivity to low doses...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38553994/a-case-of-multidrug-resistant-tuberculosis-in-an-active-duty-military-health-care-worker
#39
JOURNAL ARTICLE
Amanda E Saunders, Kevin M Shanahan, John W Downs
Cases of active tuberculosis (TB) in the U.S. Military have fallen over the last century in large part due to improved screening and treatment options. The subset of multidrug-resistant TB (MDR-TB) is almost nonexistent within the U.S. Military. We present a case of MDR-TB in an active duty U.S. Military health care worker and discuss several considerations for treatment that may present challenges for U.S. Military medical practitioners. A 30-year-old active duty Soldier was referred to Army public health services after a bronchoscopy sample was positive for Mycobacterium tuberculosis complex...
March 29, 2024: Military Medicine
https://read.qxmd.com/read/38551770/good-manufacturing-practices-production-of-human-placental-derived-mesenchymal-stem-cells-for-therapeutic-applications-focus-on-multiple-sclerosis
#40
JOURNAL ARTICLE
Ameneh Shokati, Abdorreza Naser Moghadasi, Andisheh Ghashghaei, Mohammad Ali Sahraian, Bahram Chahardouli, Seyed Asadollah Mousavi, Jafar Ai, Mohsen Nikbakht
BACKGROUND: Among neurological diseases, multiple sclerosis (MS) affects mostly young adults and can cause long-term disability. While most medications with approval from regulatory agencies are very effective in treating MS disease, they are unable to repair the tissue damage found in the central nervous system (CNS). Consequently, Cell-based therapy particularly using mesenchymal stem/stromal cells (MSCs), holds promise for neuroprotection and tissue repair in MS treatment. Furthermore, placenta-derived MSCs (PLMSCs) have shown the potential to treat MS due to their abundance, noninvasive isolation from discarded tissues, no ethical problems, anti-inflammatory, and reparative properties...
March 29, 2024: Molecular Biology Reports
keyword
keyword
9721
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.